FMC Corporation
FMC
Positions held
Your positionsFMC isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- FMC Corporation operates in the agricultural inputs industry, which is essential for food production and is expected to grow as global demand for food increases.
- In the latest quarter, FMC reported a revenue increase of 14% compared to the prior quarter, reaching $867 million.
- The gross margin improved to 39.5%, up from 32.5% in the previous quarter.
- FMC's current financial performance is concerning, with a net income loss of $186.6 million in the latest quarter.
- The company has a high debt-to-equity ratio of 265.05, indicating significant leverage and financial risk.
- FMC's overall score is a 'Strong Sell' with a score of -24.00, reflecting negative market sentiment and technical indicators.
Fundamentals
| Market cap | $1.39B | Enterprise value | $5.07B | Trailing P/E | — | Forward P/E | 5.60 |
| PEG | 1.55 | Price / book | 0.68 | Beta | 0.46 | Dividend yield | 3.59% |
| Revenue growth | -17.5% | Earnings growth | — | Gross margin | 31.9% | Operating margin | 11.8% |
| Profit margin | -84.8% | ROE | -88.4% | ROA | 0.6% | Debt / equity | 2.65 |
| Current ratio | 1.99 | Free cash flow | $165.64M | Analyst recommendation | buy | Mean target | $13.26 |
| 52w high | $31.30 | 52w low | $8.33 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $867M | $759M | $1.1B | $542M | $1.1B |
| Op margin | 11.8% | -0.5% | 18.0% | -18.8% | 15.5% |
| Net income | -$187M | -$281M | -$1.7B | -$569M | $66.7M |
| Gross margin | 39.5% | 32.5% | 39.8% | 23.8% | 38.7% |
| Gross profit | $342M | $247M | $431M | $129M | $406M |
| Operating income | $103M | -$4.0M | $195M | -$102M | $163M |
- Revenue +14% vs prior quarter ($867M vs $759M).
- Gross margin 39.5% (was 32.5% prior quarter).
- Operating margin expanded to 11.8%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.5B | $4.2B | $4.5B | $5.8B | — |
| Op margin | 9.6% | 17.1% | 17.1% | 21.3% | — |
| Net income | -$2.2B | $341M | $1.3B | $737M | — |
| Gross margin | 37.0% | 38.8% | 40.8% | 40.1% | — |
| Gross profit | $1.3B | $1.6B | $1.8B | $2.3B | — |
| Operating income | $332M | $726M | $768M | $1.2B | — |
Headlines — positive tone
• [OK · fundamentals] Stock Market Today, Oct. 6: Corteva Rallies 12% on Analyst Upgrade Following Spin Off
News
2026-10-08 · Did FMC's (FMC) Brazil Rimisoxafen Filing Just Shift Its Crop Protection Investment Narrative?
2026-10-06 · Stock Market Today, Oct. 6: Corteva Rallies 12% on Analyst Upgrade Following Spin Off
2026-10-05 · UBS Adjusts FMC Price Target to $10 From $12, Maintains Neutral Rating
2026-09-29 · The Dividend Screener Says High Yield. But These Chemical Stocks Tell a Different Story
2026-09-29 · FMC Submits Rimisoxafen Regulatory Filing for Approval in Brazil
2026-09-25 · AngloGold Ashanti Plc Announces Appointment of Non-Executive Director
2026-09-23 · FMC Says Tessenderlo Completed Minority Equity Investment for 20% Stake
2026-09-23 · FMC Corporation and Tessenderlo Group Complete Minority Equity Investment
2026-09-23 · FMC (FMC) Stock Looks Cheap Against Sales After Its 87% Fall
2026-09-21 · FMC Corporation announces date for third quarter 2026 earnings release and webcast conference call
2026-09-17 · FMC, AgroSpheres Advance Bioinsecticide Candidates Into Global Field Trials
Price (daily)
Full chart · RSI · MACD · patterns